agilon health (NYSE:AGL) Shares Down 5.2% - Here's What Happened

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) fell 5.2% during mid-day trading on Friday . The company traded as low as $3.44 and last traded at $3.41. 707,214 shares traded hands during trading, a decline of 87% from the average session volume of 5,263,885 shares. The stock had previously closed at $3.59.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. JMP Securities downgraded agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. Evercore ISI decreased their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. Royal Bank of Canada reiterated an "outperform" rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. TD Cowen decreased their price objective on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a report on Monday, November 11th. Finally, Citigroup raised shares of agilon health from a "sell" rating to a "neutral" rating and increased their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $4.03.

agilon health Trading Up 2.5 %

The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.43 billion, a PE ratio of -3.70 and a beta of 0.66. The business's fifty day moving average is $2.46 and its 200-day moving average is $3.39.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the company earned ($0.06) earnings per share. As a group, analysts anticipate that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Karen Mcloughlin purchased 25,000 shares of the company's stock in a transaction on Friday, December 13th. The shares were bought at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now owns 73,166 shares of the company's stock, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director John William Wulf acquired 45,000 shares of the stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now directly owns 206,133 shares of the company's stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 90,000 shares of company stock valued at $198,100 in the last ninety days. Corporate insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

Several hedge funds have recently modified their holdings of AGL. JPMorgan Chase & Co. boosted its stake in agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after buying an additional 1,083,492 shares in the last quarter. Inspire Investing LLC lifted its stake in agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock valued at $413,000 after buying an additional 112,241 shares in the last quarter. Citigroup Inc. boosted its holdings in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock worth $7,971,000 after buying an additional 1,941,993 shares during the period. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of agilon health in the second quarter worth approximately $1,849,000. Finally, Geode Capital Management LLC raised its holdings in shares of agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after acquiring an additional 84,889 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.